37.70MMarket Cap-688P/E (TTM)
1.4200High1.3100Low591.90KVolume1.3700Open1.3600Pre Close811.37KTurnover2.21%Turnover RatioLossP/E (Static)27.52MShares2.500052wk High-3.28P/B36.67MFloat Cap0.808052wk Low--Dividend TTM26.77MShs Float195.0000Historical High--Div YieldTTM8.09%Amplitude0.6010Historical Low1.3700Avg Price1Lot Size
Iterum Therapeutics Stock Forum
Therapeutics plc's (NASDAQ:ITRM)future prospects. Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. With the latest financial year loss of US$38m and a trailing-twelve-month loss of US$28m, the US$20m market-cap company alleviated its loss by moving closer towards its target of breakeven. The most pressing concern for investor...
No comment yet